Victor Tybulewicz group

Signal transduction from the antigen receptors of B and T cells

My group is interested in signal transduction in B and T cells, from the antigen, chemokine and cytokine receptors, as well as integrins. Signals from these receptors play critical roles in B and T cell development, activation, migration, survival and death. We are studying these processes, using gene targeting in ES cells, protein biochemistry, imaging, RNAi screens, and structural biology.  Over the last few years we have focused on the following signalling proteins: Vav1, Syk and Rac1 and Rac2.

Mouse models of Down syndrome

Trisomy of human chromosome 21 (Hsa21) occurs in ∼1 in 750 live births, and the resulting gene dosage imbalance gives rise to Down syndrome (DS), the most common known genetic form of mental retardation. In collaboration with Prof. Elizabeth Fisher (Institute of Neurology, UCL) we are interested in identifying dosage sensitive genes on Hsa21 which, when present in three copies, cause the many different phenotypes seen in DS. We are addressing this using mouse models. We have created a novel mouse strain termed Tc1 which carries a freely segregating copy of Hsa21, and which shows defects in memory, synaptic plasticity, heart development, angiogenesis and in the craniofacial skeleton. More on mouse models of Down syndrome

Selected publications

Tybulewicz group

Dr Victor Tybulewicz

Victor Tybulewicz

Recent publications

Research projects

Our research themes

Click links to view others working on these themes

Top of page

© MRC National Institute for Medical Research
The Ridgeway, Mill Hill, London NW7 1AA